ACVA (NASDAQ: ACVA) insider files to sell 5,250 common shares under Rule 144

Rhea-AI Filing Summary

ACV Auctions insider Andrew Peer plans to sell 5,250 shares of ACVA common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $46,410, while the issuer has 172,171,225 shares outstanding and the stock is listed on the NYSE.

The shares being sold were acquired on 01/15/2026 through a cash exercise of stock options. Over the prior three months, a Rule 10b5-1 trading plan for Andrew Peer sold a total of 3,500 common shares in two transactions for gross proceeds of $14,052.50 and $14,000.00. By signing, the seller represents not knowing any undisclosed material adverse information about the company.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5250	46410.00	172171225	01/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Exercise of Stock Options	Issuer			5250	01/15/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANDREW PEER 640 Ellicott Street, #321 Buffalo NY 14203	Common	12/15/2025	1750	14052.50
10b5-1 Sales for ANDREW PEER 640 Ellicott Street, #321 Buffalo NY 14203	Common	12/01/2025	1750	14000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ACVA Form 144 filing disclose?

The filing discloses that Andrew Peer plans to sell 5,250 shares of ACVA common stock under Rule 144. The sale is to be executed through Morgan Stanley Smith Barney LLC, with an aggregate market value of $46,410, and the shares were acquired by exercising stock options on 01/15/2026 for cash.

How many ACVA shares are being sold in this planned transaction?

The planned Rule 144 transaction covers 5,250 shares of ACVA common stock, with an indicated aggregate market value of $46,410 at the time of the notice.

How were the ACVA shares in the Form 144 acquired?

The shares to be sold were acquired as common stock on 01/15/2026 through an exercise of stock options from the issuer, with cash listed as the nature of payment.

What prior ACVA stock sales by Andrew Peer are disclosed?

The notice lists Rule 10b5-1 sales for Andrew Peer over the past three months: 1,750 common shares sold on 12/15/2025 for gross proceeds of $14,052.50, and another 1,750 common shares sold on 12/01/2025 for gross proceeds of $14,000.00.

How many ACVA shares are outstanding according to this Form 144?

The filing shows that 172,171,225 shares of ACVA common stock were outstanding. This figure provides a baseline to compare the size of the planned sale.

On which exchange are the ACVA shares in this Form 144 traded?

The common shares referenced in the notice are listed on the NYSE, as indicated in the securities information section.

What representation does the seller make in the ACVA Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and that this also applies as of the date of any written trading plan or instruction relied upon under Rule 10b5-1.